Beni Surpin

Beni Surpin

Spoken Languages
English Portuguese Hebrew French Spanish Italian
Beni Surpin
Los Angeles
+1 213 426 2660
Beni Surpin is a partner in the firm’s Life Sciences group, where he focuses on global technology and commercial transactions. Beni counsels international and domestic companies on a variety of legal and business issues in complex technology, intellectual property, and commercial deals across a wide range of industries, including in the life sciences, medical devices, healthcare, wireless, high-tech, automotive, aviation, food and beverage, and fashion and apparel sectors. His practice centers on complex collaborations between companies involving technology transfer and licenses, at all stages from inception to full commercialization, to generate and enhance product lines and services through access to new technologies. He works closely with clients in creating and setting strategic direction and then structuring relationships and negotiating deals to implement these goals. 

Beni’s experience covers a broad spectrum of deals and structures through collaborations, licenses and acquisitions, service-based platforms, manufacturing, supply and distribution arrangements, clinical, services, and research and development agreements, joint ventures, and strategic partnerships and alliances. He also works with private and public companies to maximize value and revenue from intellectual property and technology portfolios in a way that allows companies to optimize their assets, advising clients on a variety of related legal and business issues.

With additional experience in the areas of corporate governance and business, private equity, leveraged debt financing, and real estate investments and funds, he also guides emerging growth entities, middle market companies, and multinational corporations in their strategic planning, development and growth. 


Some of Beni’s representative clients have included Acasti Pharma, Adelson Medical Research Foundation, Alameda Health, Apotex Pharmaceuticals, ARM China, Aviation Corporation of China (AVIC), BAE Systems, BD Biosciences, Beckman Coulter, Biocept, Blue Cross Blue Shield, Brighter, Broadcom, Cambrian Biopharma, Children’s Healthcare of Atlanta, Clean Energy Fuels, Cooper Pharma, CStone Pharmaceuticals, Daiichi Sankyo, Dompé Farmaceutici, DreamWorks, EV Biologics, Excelra, Fishawack, FluGen, Genomics Institute of the Novartis Research Foundation, iHealth Lab, Innovent Biologics, J. Craig Venter Institute, Jenny Craig, Lacerta Therapeutics, Lashify, Leidos, Lufthansa, Lupin Pharmaceuticals, McKesson, Menarini Silicon Biosystems, Morningside Technology Ventures, Memorial Sloan Kettering Cancer Center, Next Proteins, Northrop Grumman Corporation, OnQuality Pharmaceuticals, Organovo, Overland Pharmaceuticals, Reflexion Health, Rezatec, Robin Healthcare, SAIC, SecurityPoint Media, Snap, Taylor Made Golf, Therapeutics Inc., Therapeutics MD, Thermo Fisher Scientific, and Zymochem

Professional Experience

Beni started his legal career at Norton Rose in London. Prior to joining Goodwin, he headed the global technology, intellectual property and commercial transactions group at another international law firm, and most recently was a partner at Foley & Larder. He also previously resided in the UK, Brazil and Israel.




University of Cambridge

Jesus College

(with honors)


University of Oxford

St. Edmund Hall


University of Oxford

(with honors)



  • California
  • District of Columbia
  • England & Wales

Recognition & Awards

  • Selected to the 2023 Top 50 Lawyers In America list by America’s Top Lawyers
  • The Legal 500 for ERISA litigation, large M&A deals ($1bn+), technology transactions, M&A deals (venture capital and emerging companies), technology in both outsourcing and data protection and privacy, healthcare and life sciences and patent licensing (Tier 1)
  • Voted Global Technology Transactions Expert of the Year in California by The Lawyer Network

  • Voted Technology Licensing Lawyer of the Year in California by Corporate INTL Global Awards
  • Chambers USA: America’s Leading Lawyers for Business notes that Mr. Surpin wins plaudits for his brilliance as a practitioner, and is a growing presence in the legal community. Chambers also notes that “sources compliment his ‘amazing command of the law,’ which ‘is blended with practical consideration of what drives business.’”
  • Southern California Super Lawyers®
  • Voted Best of the Bar by the San Diego Business Journal
  • Winner of the Finance Monthly Deal Maker of the Year Award
  • Voted one of the Best Lawyers in San Diego by LegalForce
  • Voted San Diego Top Attorney by the Daily Transcript for IP Transactional and Corporate Transactional


Beni regularly speaks, authors and teaches on a variety of technology transfer and collaboration related topics, covering the most recent business strategies, legal debates, challenges and solutions on maximizing value and revenue from intellectual property both in the US and globally.

  • Speaker, Playing on a Global Stage: Understanding Cyber Trends and Making the Big Deals,” Cyber Week Tel Aviv, June 29, 2022